Bharat Biotech's partner seeks Covaxin nod in US for children between 2 and 18 years

Bharat Biotech's partner seeks Covaxin nod in US for children between 2 and 18 years The US-based firm has applied for the authorisation based on the basis of the results of phase 2 and 3 clinical trials conducted on 526 children aged between 2 and 18 years of age in India. https://ift.tt/eA8V8J